http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102258812-B
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_790487ba0beeececc90c42eb948f6b63 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-18 |
filingDate | 2011-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2013-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83bbcb451801099cd3241faa4f7bd077 |
publicationDate | 2013-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-102258812-B |
titleOfInvention | Phase-change-controllable embolic material and preparation method thereof |
abstract | The invention relates to an embolic material, particularly a phase-change-controllable embolic material applicable to medicine and a preparation method thereof. The phase-change-controllable embolic material is prepared from a temperature-sensitive polymer water solution and a mixed developer, and is characterized in that the mixed developer comprises Iohexol and iodized oil; the mass percent of the mixed developer in the liquid embolic material is 30-80%; and the iodized oil accounts for 3-60% (volume percent) of the embolic material liquid solution. When the ambient temperature reaches the body temperature, the phase-change-controllable embolic material precipitates into solid to perform the embolic function, and the imaging appearance of the solid in the operation is clear, so that the clinician can directly observe and determine the position and flow direction of the embolic material, thereby avoiding ectopic embolism and greatly enhancing the safety of the operation. |
priorityDate | 2011-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 25.